Director
CurrentCurrently I am the leader of an analytical team within the drug product development organization, where our team's mission is to develop and deliver a right first time integrated analytical control strategy with an emphasis on oral solid formulations from discovery to commercial. In addition, I am a matrix leader for two biologic drug product development teams tasked with enabling FIH to commercial formulation development. Prior to joining the drug product development organization, I had significant experience across all phases of development in small molecule analytical chemistry including both drug substance and drug product.